Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Riazi

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Plos One|January 7, 2014
Pentavalent single-domain antibodies reduce Campylobacter jejuni motility and colonization in chickensAli Riazi, Philippa C R Strong, Russell Coleman, et al.
Journal of Alzheimer'S Disease : JAD|May 30, 2023
Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's DiseaseSaeed Karima, Vajiheh Aghamollaii, Somayeh Mahmoodi Baram, et al.
Brain Injury|April 6, 2022
Boswellia serrata extract shows cognitive benefits in a double-blind, randomized, placebo-controlled pilot clinical trial in individuals who suffered traumatic brain injuryShakila Meshkat, Somayeh Mahmoodi Baram, Shima Rajaei, et al.
Inflammopharmacology|October 2, 2025
Boswellic acids as an adjunct therapy in Parkinson's disease: a double-blind clinical trial investigating on its effects on motor symptoms and inflammatory markersSomayyeh Shateri, Seyyed Hossein Khatami, Sajad Ehtiati, et al.
Journal of Dietary Supplements|February 27, 2025
Boswellic Acids Reduce Systemic Inflammation in Patients with Moderate COVID-19 Through Modulation of NF-κB PathwaySepideh Barzin Tond, Sara Abolghasemi, Seyyed Hossein Khatami, et al.
Inflammopharmacology|February 24, 2022
Inflawell<sup>®</sup> improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trialSepideh Barzin Tond, Laurent Balenci, Nasim Khajavirad, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Plos One|January 7, 2014
Pentavalent single-domain antibodies reduce Campylobacter jejuni motility and colonization in chickensAli Riazi, Philippa C R Strong, Russell Coleman, et al.
Journal of Alzheimer'S Disease : JAD|May 30, 2023
Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's DiseaseSaeed Karima, Vajiheh Aghamollaii, Somayeh Mahmoodi Baram, et al.
Brain Injury|April 6, 2022
Boswellia serrata extract shows cognitive benefits in a double-blind, randomized, placebo-controlled pilot clinical trial in individuals who suffered traumatic brain injuryShakila Meshkat, Somayeh Mahmoodi Baram, Shima Rajaei, et al.
Inflammopharmacology|October 2, 2025
Boswellic acids as an adjunct therapy in Parkinson's disease: a double-blind clinical trial investigating on its effects on motor symptoms and inflammatory markersSomayyeh Shateri, Seyyed Hossein Khatami, Sajad Ehtiati, et al.
Journal of Dietary Supplements|February 27, 2025
Boswellic Acids Reduce Systemic Inflammation in Patients with Moderate COVID-19 Through Modulation of NF-κB PathwaySepideh Barzin Tond, Sara Abolghasemi, Seyyed Hossein Khatami, et al.
Inflammopharmacology|February 24, 2022
Inflawell<sup>®</sup> improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trialSepideh Barzin Tond, Laurent Balenci, Nasim Khajavirad, et al.
Pageof 4